There is no single best or “richest” source for every use. Blood-forming transplant cells can come from peripheral blood, bone marrow or cord blood; other cell products use different tissues and manufacturing methods. The relevant cell population, quality and clinical purpose matter more than a marketing claim about abundance. National Cancer Institute: blood stem cell transplantation. See patient-derived and donor-derived cells.
On this page
Abundance is not the same as usefulness
Ask what cell population is counted and how it relates to the proposed treatment. Different collection and processing methods cannot be compared only by a headline number. The clinical question is whether the final preparation meets appropriate quality requirements and has evidence for the intended use, not whether a tissue is promoted as especially rich.
Questions to take to a consultation
- Which cell population is present in the final product?
- What does the quoted count actually measure?
- Which clinical evidence supports that source and preparation?
Request clear written answers and discuss unresolved points with a clinician familiar with your history before committing to a product or procedure.
Related questions
Return to the FAQ index to browse all questions and the detailed decision guides.
Ask about an assessment
For questions about the review process, availability or a written estimate, message Thailand Stem Cell Clinic. Ask how to share records securely. An enquiry does not confirm eligibility or that a particular treatment is offered.
All FAQs · Treatment guides · Contact information
Sources and further reading
General information, not an individual medical recommendation. Prices, coverage, eligibility and authorisation require case-specific confirmation. Source links describe their own research and jurisdictions.